Literature DB >> 8634606

Primary HIV-1 infection: a new medical emergency?

S Jolles, S Kinloch de Loës, M A Johnson, G Janossy.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8634606      PMCID： PMC2351063          DOI： 10.1136/bmj.312.7041.1243

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Characterization of the acute clinical illness associated with human immunodeficiency virus infection.

Authors:  B Tindall; S Barker; B Donovan; T Barnes; J Roberts; C Kronenberg; J Gold; R Penny; D Cooper
Journal:  Arch Intern Med       Date:  1988-04

2.  Time to hit HIV, early and hard.

Authors:  D D Ho
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

3.  A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Authors:  S Kinloch-De Loës; B J Hirschel; B Hoen; D A Cooper; B Tindall; A Carr; J H Saurat; N Clumeck; A Lazzarin; L Mathiesen
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

4.  Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases.

Authors:  S Kinloch-de Loës; P de Saussure; J H Saurat; H Stalder; B Hirschel; L H Perrin
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

5.  Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

Authors:  S Lindbäck; C Broström; A Karlsson; H Gaines
Journal:  BMJ       Date:  1994-12-10

6.  Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion.

Authors:  D A Cooper; J Gold; P Maclean; B Donovan; R Finlayson; T G Barnes; H M Michelmore; P Brooke; R Penny
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321
  6 in total
  1 in total

1.  Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment.

Authors:  M R Wallace; J A Nelson; J A McCutchan; T Wolfson; I Grant
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.